Revenue Growth and Profitability
Jushi reported a revenue increase to $65.7 million, a year-over-year growth of $4.1 million. Gross profit for the third quarter was $30.7 million, representing 46.7% of revenue, marking an improvement from previous periods. Adjusted EBITDA was $12.8 million, up from $10.3 million in Q3 of 2024.
Operational Enhancements
Operational improvements led to higher yields and potency levels in cultivation. Yields climbed to 84 grams per square foot, a 13% increase year-over-year, and potency levels averaged 27% THCa, 10.5% above the 2025 target.
Retail and Wholesale Expansion
Jushi expanded its retail footprint with 8 new stores by the end of the year and increased wholesale revenue by $1.3 million sequentially. Ohio showed strong performance with a 2.4x increase in cannabis sales year-over-year.
Strategic Investments
Investments in high-return projects, especially in grower-processor facilities in Pennsylvania and Virginia, continue to strengthen Jushi's supply chain for both medical and adult use.